Search research articles
Contact Us
Filters
Showing results (91-100 of 136) with videos related to
Page
of 14
Sort By:
Human Molecular Genetics
|
July 1, 1997
Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy
L Metzinger, D J Blake, M V Squier, et al.
Talanta
|
October 5, 2014
HS-GC-MS method for the analysis of fragrance allergens in complex cosmetic matrices
B Desmedt, M Canfyn, M Pype, et al.
Pathologie-Biologie
|
May 31, 2014
Diagnosis and management of nocardiosis after bone marrow stem cell transplantation in adults: lack of lymphocyte recovery as a major contributing factor
L Mansi, E Daguindau, P Saas, et al.
International Journal of Medical Informatics
|
September 11, 2010
Computerized physician order entry of injectable antineoplastic drugs: an epidemiologic study of prescribing medication errors
V Nerich, S Limat, M Demarchi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2000
Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapy
S Limat, M C Woronoff-Lemsi, N Milpied, et al.
Presse Medicale (Paris, France : 1983)
|
January 7, 1995
[Listeriosis in patients with malignant hemopathy. 3 cases in the same hospital ward]
J Fontan, A Brion, E Deconinck, et al.
Journal of Chromatographic Science
|
November 15, 2008
Evaluation of orthogonal/dissimilar RP-HPLC systems sets for their suitability as method-development starting points for drug impurity profiles
E Van Gyseghem, E Deconinck, M Dumarey, et al.
Bone Marrow Transplantation
|
July 28, 2010
Early immune reconstitution and efficient graft vs tumor effect after unrelated partially matched double cord blood transplantation in refractory 8p11 syndrome
F Larosa, S Maddens, F Legrand, et al.
Blood
|
October 15, 1992
Prevention of veno-occlusive disease of the liver after bone marrow transplantation: heparin or no heparin?
J Y Cahn, M Flesch, A Brion, et al.
Gene Therapy
|
April 26, 2016
Exposure to hypomethylating agent, 5-azacytidine, may improve iCasp9 suicide gene therapy for treating GvHD in allografts
E Bôle-Richard, C Gamonet, J-M Certoux, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 136) with videos related to
Sort By:
Page
of 14
Human Molecular Genetics
|
July 1, 1997
Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy
L Metzinger, D J Blake, M V Squier, et al.
Talanta
|
October 5, 2014
HS-GC-MS method for the analysis of fragrance allergens in complex cosmetic matrices
B Desmedt, M Canfyn, M Pype, et al.
Pathologie-Biologie
|
May 31, 2014
Diagnosis and management of nocardiosis after bone marrow stem cell transplantation in adults: lack of lymphocyte recovery as a major contributing factor
L Mansi, E Daguindau, P Saas, et al.
International Journal of Medical Informatics
|
September 11, 2010
Computerized physician order entry of injectable antineoplastic drugs: an epidemiologic study of prescribing medication errors
V Nerich, S Limat, M Demarchi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2000
Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapy
S Limat, M C Woronoff-Lemsi, N Milpied, et al.
Presse Medicale (Paris, France : 1983)
|
January 7, 1995
[Listeriosis in patients with malignant hemopathy. 3 cases in the same hospital ward]
J Fontan, A Brion, E Deconinck, et al.
Journal of Chromatographic Science
|
November 15, 2008
Evaluation of orthogonal/dissimilar RP-HPLC systems sets for their suitability as method-development starting points for drug impurity profiles
E Van Gyseghem, E Deconinck, M Dumarey, et al.
Bone Marrow Transplantation
|
July 28, 2010
Early immune reconstitution and efficient graft vs tumor effect after unrelated partially matched double cord blood transplantation in refractory 8p11 syndrome
F Larosa, S Maddens, F Legrand, et al.
Blood
|
October 15, 1992
Prevention of veno-occlusive disease of the liver after bone marrow transplantation: heparin or no heparin?
J Y Cahn, M Flesch, A Brion, et al.
Gene Therapy
|
April 26, 2016
Exposure to hypomethylating agent, 5-azacytidine, may improve iCasp9 suicide gene therapy for treating GvHD in allografts
E Bôle-Richard, C Gamonet, J-M Certoux, et al.
Page
of 14